Amneal Pharmaceuticals to Acquire Kashiv BioSciences to Create Integrated Global Biosimilar Platform
Amneal Pharmaceuticals to buy Kashiv BioSciences, accelerating biosimilar pipeline and strengthening US market position for affordable medicines.
Biosimilars Acquisition Deal | 23/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy